Company Filing History:
1 out of 2,405 
1 out of 55 Years Active: 2020
Title: Inventor Jerelyn Wong: Pioneering Anti-CD27 Antibodies
Introduction
Jerelyn Wong, located in San Jose, CA, has made significant contributions to the field of biotechnology through her innovative work in antibody development. With a focus on therapeutic applications, Wong has developed a patent that potentially addresses critical health issues, including cancer and infectious diseases.
Latest Patents
Jerelyn Wong holds a patent for anti-CD27 antibodies. This invention pertains to the use of these antibodies in treating various ailments, particularly cancer and infectious diseases. The development of such antibodies represents a significant advance in targeted therapies that can improve patient outcomes.
Career Highlights
Jerelyn Wong has gathered valuable experience working with prominent companies in the pharmaceutical industry. She has been associated with Merck Sharp & Dohme Corporation and Merck Sharp & Dohme B.V., where she collaborated with leading experts in her field to advance therapeutic innovations.
Collaborations
Throughout her career, Wong has worked alongside notable colleagues such as Amy M Beebe and Jason Ka Jen Cheung. These collaborations have fostered a dynamic exchange of ideas and expertise, contributing to the successful development of her patented technologies.
Conclusion
Jerelyn Wong stands out as an influential figure in biotechnology, particularly for her work on anti-CD27 antibodies. Her patent not only represents a personal achievement but also embodies the potential for significant advancements in the treatment of serious diseases. As she continues her work, the impact of her innovations will likely resonate across the medical field and beyond.